Key Points
- CEO R. Dirk Allison sold shares: Allison sold 4,988 shares on Feb. 24 at $106.98 and 2,364 shares on Feb. 25 at $105.36 — roughly 7,352 shares totaling about $782,687 — and now owns 185,514 shares (~$19.85M), a ~2.6% reduction in his stake.
- Concentrated insider selling coincided with a share pullback: Multiple insiders sold on Feb. 24–25 and the stock traded down about 3.3%, a pattern that can add downward pressure or signal executives taking profits.
- Market positioning and sentiment: Short interest rose materially to roughly 1,148,513 shares (~6.5% of shares sold short, ~4.6 days to cover) while analysts maintain a consensus "Moderate Buy" with an average target near $134.33 and institutional ownership at ~95.4%.
Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) EVP Cliff Donald Blessing sold 177 shares of Addus HomeCare stock in a transaction on Wednesday, February 25th. The shares were sold at an average price of $105.36, for a total value of $18,648.72. Following the completion of the transaction, the executive vice president owned 12,361 shares in the company, valued at $1,302,354.96. The trade was a 1.41% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Cliff Donald Blessing also recently made the following trade(s):
- On Tuesday, February 24th, Cliff Donald Blessing sold 350 shares of Addus HomeCare stock. The stock was sold at an average price of $107.14, for a total value of $37,499.00.
Addus HomeCare Trading Down 0.5%
Shares of Addus HomeCare stock traded down $0.51 during trading hours on Friday, reaching $103.52. The stock had a trading volume of 14,471 shares, compared to its average volume of 233,037. The firm has a market capitalization of $1.92 billion, a price-to-earnings ratio of 19.85, a P/E/G ratio of 1.49 and a beta of 0.91. Addus HomeCare Corporation has a 1 year low of $88.96 and a 1 year high of $124.43. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.11. The firm has a 50 day simple moving average of $109.41 and a two-hundred day simple moving average of $113.01.
Addus HomeCare News Summary
Here are the key news stories impacting Addus HomeCare this week:
- Positive Sentiment: Stephens retained an "Overweight" rating on ADUS and set a $135 price target (trimmed from $140), keeping a constructive analyst opinion that supports medium-term upside. Read More.
- Positive Sentiment: Large institutional investors increased positions in recent quarters (Capital Research, Vanguard, Wasatch, State Street and others), signaling continued institutional confidence and buying power underneath the stock. Read More.
- Neutral Sentiment: Short-interest reporting is inconsistent across feeds (some entries show 0 shares, others show a material rise), creating data noise — investors should confirm with official FINRA/exchange data before sizing positions. Read More.
- Negative Sentiment: Insiders sold multiple tranches of stock on Feb. 24–25: CEO R. Dirk Allison sold several thousand shares (~7,300 across filings) and numerous EVPs also liquidated positions — concentrated insider selling often weighs on sentiment and can pressure the share price. Read More.
- Negative Sentiment: Reported short interest increased materially in February to roughly 1.15M shares (~6.5% of float, ~4.6 days to cover in mid-February) — a larger short book can amplify downside on negative headlines and increase volatility. Read More.
- Negative Sentiment: Media picked up a "pessimistic forecast" narrative tied to Stephens' shorter-term expectations after the PT cut, which can reinforce selling pressure despite the retained Overweight rating. Read More.
Institutional Trading of Addus HomeCare
Several hedge funds and other institutional investors have recently bought and sold shares of ADUS. Capital Research Global Investors raised its stake in Addus HomeCare by 22.3% during the fourth quarter. Capital Research Global Investors now owns 1,469,752 shares of the company's stock valued at $157,837,000 after buying an additional 268,192 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of Addus HomeCare by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company's stock valued at $140,531,000 after acquiring an additional 10,501 shares during the last quarter. Wasatch Advisors LP raised its position in shares of Addus HomeCare by 0.8% during the 3rd quarter. Wasatch Advisors LP now owns 936,243 shares of the company's stock valued at $110,467,000 after acquiring an additional 7,089 shares in the last quarter. State Street Corp lifted its stake in Addus HomeCare by 0.9% during the fourth quarter. State Street Corp now owns 702,229 shares of the company's stock worth $75,412,000 after purchasing an additional 6,561 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in Addus HomeCare by 1.2% in the third quarter. Dimensional Fund Advisors LP now owns 667,256 shares of the company's stock worth $78,729,000 after purchasing an additional 7,884 shares during the period. 95.35% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on ADUS shares. Stephens dropped their price objective on shares of Addus HomeCare from $140.00 to $135.00 and set an "overweight" rating on the stock in a research note on Wednesday. TD Cowen reaffirmed a "buy" rating on shares of Addus HomeCare in a report on Wednesday, November 5th. Barclays cut their price objective on shares of Addus HomeCare from $117.00 to $112.00 and set an "underweight" rating on the stock in a report on Tuesday. Truist Financial set a $135.00 target price on Addus HomeCare and gave the stock a "buy" rating in a research report on Wednesday, January 7th. Finally, Royal Bank Of Canada reissued an "outperform" rating and issued a $139.00 price target on shares of Addus HomeCare in a report on Wednesday. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $134.33.
Check Out Our Latest Stock Analysis on Addus HomeCare
Addus HomeCare Company Profile
(
Get Free Report)
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients' independence and quality of life.
The company's core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
